In line with the suggestion that S100A2 be considered as a tumor-suppressor candidate, our study suggests that S100A2 may prevent laryngeal cancer cells from invading and migrating in vitro via the p53 signaling pathway. Here, TP53 is linked to laryngeal carcinoma.